Seagen Inc. SGEN announced that its current chief executive officer (“CEO”), president and member of board of directors, Dr. Clay Siegall, has resigned from all of his current positions. Roger Dansey, ...

A police report of the domestic abuse arrest of Seagen CEO Clay Siegall, Ph.D., describes a drunken night involving him, his wife and another couple and includes sexual escapades and alleged violence ...

In May of last year, after Seagen rejected Merck’s offer to acquire it for $230 per share, the Seattle biotech saw its value tumble. Just three months later, Merck’s offer had dropped to $195 per ...

(Reuters) -Pfizer said on Tuesday it expects to close its $43 billion deal to buy cancer drugmaker Seagen later this week and plans to create a new oncology division that includes the acquisition ...

BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced plans to build a new facility in Everett, Washington, to expand the company’s biomanufacturing capacity and enable the ...

Pfizer is set to acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise ...

When it comes to churning out medicines that fight cancer, Seagen (NASDAQ: SGEN) is a heavyweight. The biotech's global footprint is expanding thanks to regulatory approvals in Europe, and its sales ...

Seagen Inc. SGEN reported a loss of 73 cents per share in the second quarter of 2022, narrower than the Zacks Consensus Estimate of a loss of 82 cents. The company had reported a loss of 47 cents per ...

NICE has decided not to recommend Seagen's orally-active HER2 inhibitor Tukysa for advanced breast cancer in draft guidance, saying it isn't a cost-effective use of NHS resources. Tukysa (tucatinib) ...

Washington-headquartered Seagen expects to make around $2.2bn in revenue this year, while Pfizer cements its position in cancer medication. Pharmaceutical giant Pfizer is set to acquire cancer-focused ...

Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, ...